Cargando…
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
INTRODUCTION: Mitochondrial fatty acid oxidation disorders (FAODs) are a heterogeneous group of hereditary autosomal recessive diseases included in newborn screening (NBS) program in Italy. The aim of this study was to analyse FAODs cases, identified either clinically or by NBS,for clinical and gene...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414009/ https://www.ncbi.nlm.nih.gov/pubmed/32793418 http://dx.doi.org/10.1016/j.ymgmr.2020.100632 |
_version_ | 1783568897221328896 |
---|---|
author | Maguolo, A. Rodella, G. Dianin, A. Nurti, R. Monge, I. Rigotti, E. Cantalupo, G. Salviati, L. Tucci, S. Pellegrini, F. Molinaro, G. Lupi, F. Tonin, P. Pasini, A. Campostrini, N. Ion Popa, F. Teofoli, F. Vincenzi, M. Camilot, M. Piacentini, G. Bordugo, A. |
author_facet | Maguolo, A. Rodella, G. Dianin, A. Nurti, R. Monge, I. Rigotti, E. Cantalupo, G. Salviati, L. Tucci, S. Pellegrini, F. Molinaro, G. Lupi, F. Tonin, P. Pasini, A. Campostrini, N. Ion Popa, F. Teofoli, F. Vincenzi, M. Camilot, M. Piacentini, G. Bordugo, A. |
author_sort | Maguolo, A. |
collection | PubMed |
description | INTRODUCTION: Mitochondrial fatty acid oxidation disorders (FAODs) are a heterogeneous group of hereditary autosomal recessive diseases included in newborn screening (NBS) program in Italy. The aim of this study was to analyse FAODs cases, identified either clinically or by NBS,for clinical and genetic characterization and to evaluate a five years' experience of NBS, in the attempt to figure out the complexity of genotype-phenotype correlation and to confirm the clinical impact of NBS in our centre experience. MATERIALS AND METHODS: We analysed FAODs patients diagnosed either by NBS or clinically, followed since February 2014 to April 2019 at the Regional Screening Centre and Inherited Metabolic Diseases Unit of Verona. Diagnosis was confirmed by plasma acylcarnitines, urinary organic acids, enzymatic and genetic testing. For not clear genotypes due to the presence of variants of uncertain significance, in silico predictive tools have been used as well as enzymatic activity assays. Patients underwent clinical, nutritional and biochemical follow up. RESULTS: We diagnosed 30 patients with FAODs. 20 by NBS: 3 CUD, 6 SCADD, 5 MCADD, 4 VLCADD, 2 MADD. Overall incidence of FAODs diagnosed by NBS was 1:4316 newborns. No one reported complications during the follow up period. 10 patients were diagnosed clinically: 2 CUD, 2 CPT2D, 1 VLCADD, 5 MADD. Mean age at diagnosis was 29.3 years. Within this group, complications or symptoms were reported at diagnosis, but not during follow-up. 12 mutations not previously reported in literature were found, all predicted as pathogenic or likely pathogenic. DISCUSSION AND CONCLUSIONS: Our study highlighted the great phenotypic variability and molecular heterogeneity of FAODs and confirmed the importance of a tailored follow up and treatment. Despite the short duration of follow up, early identification by NBS prevented diseases related complications and resulted in normal growth and psycho-motor development as well. |
format | Online Article Text |
id | pubmed-7414009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-74140092020-08-12 Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience Maguolo, A. Rodella, G. Dianin, A. Nurti, R. Monge, I. Rigotti, E. Cantalupo, G. Salviati, L. Tucci, S. Pellegrini, F. Molinaro, G. Lupi, F. Tonin, P. Pasini, A. Campostrini, N. Ion Popa, F. Teofoli, F. Vincenzi, M. Camilot, M. Piacentini, G. Bordugo, A. Mol Genet Metab Rep Research Paper INTRODUCTION: Mitochondrial fatty acid oxidation disorders (FAODs) are a heterogeneous group of hereditary autosomal recessive diseases included in newborn screening (NBS) program in Italy. The aim of this study was to analyse FAODs cases, identified either clinically or by NBS,for clinical and genetic characterization and to evaluate a five years' experience of NBS, in the attempt to figure out the complexity of genotype-phenotype correlation and to confirm the clinical impact of NBS in our centre experience. MATERIALS AND METHODS: We analysed FAODs patients diagnosed either by NBS or clinically, followed since February 2014 to April 2019 at the Regional Screening Centre and Inherited Metabolic Diseases Unit of Verona. Diagnosis was confirmed by plasma acylcarnitines, urinary organic acids, enzymatic and genetic testing. For not clear genotypes due to the presence of variants of uncertain significance, in silico predictive tools have been used as well as enzymatic activity assays. Patients underwent clinical, nutritional and biochemical follow up. RESULTS: We diagnosed 30 patients with FAODs. 20 by NBS: 3 CUD, 6 SCADD, 5 MCADD, 4 VLCADD, 2 MADD. Overall incidence of FAODs diagnosed by NBS was 1:4316 newborns. No one reported complications during the follow up period. 10 patients were diagnosed clinically: 2 CUD, 2 CPT2D, 1 VLCADD, 5 MADD. Mean age at diagnosis was 29.3 years. Within this group, complications or symptoms were reported at diagnosis, but not during follow-up. 12 mutations not previously reported in literature were found, all predicted as pathogenic or likely pathogenic. DISCUSSION AND CONCLUSIONS: Our study highlighted the great phenotypic variability and molecular heterogeneity of FAODs and confirmed the importance of a tailored follow up and treatment. Despite the short duration of follow up, early identification by NBS prevented diseases related complications and resulted in normal growth and psycho-motor development as well. Elsevier 2020-08-05 /pmc/articles/PMC7414009/ /pubmed/32793418 http://dx.doi.org/10.1016/j.ymgmr.2020.100632 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Maguolo, A. Rodella, G. Dianin, A. Nurti, R. Monge, I. Rigotti, E. Cantalupo, G. Salviati, L. Tucci, S. Pellegrini, F. Molinaro, G. Lupi, F. Tonin, P. Pasini, A. Campostrini, N. Ion Popa, F. Teofoli, F. Vincenzi, M. Camilot, M. Piacentini, G. Bordugo, A. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience |
title | Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience |
title_full | Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience |
title_fullStr | Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience |
title_full_unstemmed | Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience |
title_short | Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience |
title_sort | diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: a single centre experience |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414009/ https://www.ncbi.nlm.nih.gov/pubmed/32793418 http://dx.doi.org/10.1016/j.ymgmr.2020.100632 |
work_keys_str_mv | AT maguoloa diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT rodellag diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT dianina diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT nurtir diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT mongei diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT rigottie diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT cantalupog diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT salviatil diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT tuccis diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT pellegrinif diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT molinarog diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT lupif diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT toninp diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT pasinia diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT campostrinin diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT ionpopaf diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT teofolif diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT vincenzim diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT camilotm diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT piacentinig diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience AT bordugoa diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience |